Using LanM Enzymes to Modify Glucagon-Like Peptides 1 and 2 in E.coli

Area of Science:

• Biochemistry
• Peptide Chemistry
• Synthetic Biology

Background:

• Bioactive peptides often require modification for improved pharmaceutical properties like stability and potency.
• Ribosomally synthesized and post-translationally modified peptides (RiPPs) utilize specific enzymes and leader peptides for selective modifications.
• Glucagon-like peptides (GLP) 1 and 2 are critical hormones with therapeutic potential.

Purpose of the Study:

• To investigate the post-translational installation of D-alanine into GLP-1 and GLP-2 using RiPP machinery.
• To explore how precursor peptide design impacts the selectivity and pattern of peptide modifications.
• To leverage natural enzymatic systems for engineered peptide therapeutics.

Main Methods:

• Utilized leader peptides and cognate enzymes from RiPP pathways.
• Engineered precursor peptides for GLP-1 and GLP-2.
• Investigated the site-specific incorporation of D-alanine.
• Analyzed modification patterns based on precursor design.

Main Results:

• Successfully demonstrated the post-translational installation of D-alanine in GLP-1 and GLP-2.
• Showcased the ability of leader peptides and enzymes to guide modifications to specific positions.
• Identified that precursor peptide modifications can modulate the resulting modification pattern.
• Provided insights into the enzyme-substrate interactions within RiPP systems.

Conclusions:

• Leader-guided enzymatic systems offer a powerful tool for selective peptide modification.
• Engineered D-alanine incorporation in GLP-1 and GLP-2 is feasible and can be modulated by precursor design.
• This approach holds promise for developing next-generation peptide-based therapeutics with enhanced properties.